The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
Clinical trial NCT07617246 · RECRUITING
Trial details
- NCT number
- NCT07617246
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-01-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.